Altrafin AG’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.96M Sell
11,931
-4,758
-29% -$1.76M 1.94% 17
2026
Q1
$4.52M Sell
16,689
-16,076
-49% -$4.79M 1.56% 20
2025
Q4
$10.8M Buy
32,765
+16,260
+99% +$5.51M 3.43% 10
2025
Q3
$5.7M Buy
16,505
+3,047
+23% +$922K 1.81% 19
2025
Q2
$4.2M Sell
13,458
-13,954
-51% -$5.33M 1.42% 24
2025
Q1
$14.4M Sell
27,412
-1,379
-5% -$705K 5.58% 5
2024
Q4
$14.6M Buy
28,791
+3,956
+16% +$2.25M 5.05% 6
2024
Q3
$14.5M Buy
24,835
+22,965
+1,228% +$13M 5.23% 6
2024
Q2
$952K Buy
1,870
+35
+2% +$17.2K 0.35% 44
2024
Q1
$908K Hold
1,835
0.33% 46
2023
Q4
$966K Sell
1,835
-240
-12% -$128K 0.37% 46
2023
Q3
$1.05M Sell
2,075
-1,170
-36% -$576K 0.46% 45
2023
Q2
$1.56M Buy
3,245
+60
+2% +$29.3K 0.7% 38
2023
Q1
$1.51M Buy
3,185
+300
+10% +$145K 0.74% 34
2022
Q4
$1.53M Buy
2,885
+60
+2% +$31.8K 0.9% 32
2022
Q3
$1.43M Sell
2,825
-135
-5% -$71K 0.85% 35
2022
Q2
$1.52M Sell
2,960
-180
-6% -$90.4K 0.82% 35
2022
Q1
$1.6M Buy
3,140
+116
+4% +$55.9K 0.63% 38
2021
Q4
$1.52M Buy
+3,024
New +$1.37M 0.55% 48

Other funds holding UNH

Altrafin AG's UNH Position: Q2 2026 in Review

Altrafin AG reduced its UnitedHealth (UNH) stake by 29% in Q2 2026, selling an estimated $1.76M and leaving 11,931 shares worth $4.96M. The position accounts for 1.94% of the portfolio, ranked #17.

Altrafin AG first reported a position in UNH in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.6M in Q4 2024. 3,372 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Altrafin AG held 11,931 shares of UnitedHealth worth $4.96M as of Q2 2026.
  • Altrafin AG sold 4,758 UnitedHealth shares in Q2 2026, an estimated $1.76M.
  • UnitedHealth made up 1.94% of Altrafin AG's portfolio in Q2 2026, its #17 holding.
  • Altrafin AG first reported a position in UnitedHealth in Q4 2021 and has held it in 19 quarters since.
  • Altrafin AG's UnitedHealth position peaked at $14.6M in Q4 2024.
  • 3,372 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.